SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,114,000 | -10.0% | 149,430 | +2.5% | 0.03% | +3.1% |
Q2 2020 | $3,460,000 | +58.1% | 145,725 | +19.8% | 0.03% | +60.0% |
Q1 2020 | $2,189,000 | -42.8% | 121,688 | -24.6% | 0.02% | -13.0% |
Q4 2019 | $3,826,000 | +96.8% | 161,313 | +128.0% | 0.02% | +109.1% |
Q3 2019 | $1,944,000 | -35.1% | 70,746 | -21.8% | 0.01% | -31.2% |
Q2 2019 | $2,995,000 | +1.5% | 90,522 | +7.5% | 0.02% | +6.7% |
Q1 2019 | $2,952,000 | +708.8% | 84,236 | +1061.7% | 0.02% | +650.0% |
Q3 2018 | $365,000 | -14.1% | 7,251 | +2.2% | 0.00% | 0.0% |
Q2 2018 | $425,000 | – | 7,093 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |